GT-001

· Gila Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GT-001, covering 2018-04-06 to 2018-04-06. Get the full timeline:

Most recent: Clinical Trial Update: A Dose Escalating Study to Assess the Safety and Tolerability of GT-001 [Phase 1]